Milan, Italy – March 17, 2016 – Zambon S.p.A., an international pharmaceutical company strongly committed to the central nervous system (CNS) therapeutic area, today announced a strategic agreement with US WorldMeds to commercialize Newron’s lead compound, Xadago (safinamide), for the treatment of Parkinson’s disease in the U.
AFP photographer Ed Jones captures the harsh realities of life in the poverty-stricken rural villages along North Korea’s eastern coast. Ra In-Hae, 46, stands outside […]
“Fortunately, complementing his (President Mnangagwa) economic vision, the country’s odds seem en-route to becoming the region’s economic powerhouse, with even the International Monetary Fund (IMF) […]
•Ray Ekpu, Reuben Abati, Abimbola Adelaku, Dr Ugoji Egbujo, Adekunle Salami. Compiled by Oghene Omonisa. The Olympic games end tomorrow in Rio, Brazil. The dismal […]
Click and subscribe my channel. Different trends of the internal opposition met with the adviser of international mediator Lakhdar Brahimi this Thursday in Damascus. They […]